Real-world study of advanced breast cancer treatments withdrawn before starting
Knowledge-focused
Terminated
This was an observational study designed to collect medical data from people with HR+/HER2- advanced breast cancer during routine care. The goal was to track treatment effectiveness and side effects in real-world settings. However, the study was withdrawn before enrolling any par…
Sponsor: SciClone Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC